The American Diabetes Association Standards of Care acknowledge gastrointestinal tolerability as a key consideration when initiating GLP-1 receptor agonist therapy, recommending gradual dose titration to minimize these effects
Theyre going to have to look at every single thing and trim dollars everywhere they can. Pennsylvania was looking for cost-saving strategies even before the new federal tax-and-spending law, according to Brandon Cwalina, press secretary for the states Department of Human Services
Other unmeasured factors may still influence risk
Therefore, therapy primarily focuses on providing patients with supportive care to manage their symptoms using dietary supplements [9]
Eligibility for prescription treatments is determined by a licensed clinician based on medical history, laboratory testing, and clinical judgment
There are a variety of reasons why people respond differently to GLP-1 medications, including demographic, body composition, health, lifestyle and environmental factors